- Home
- GALT vs REFI Comparison
GALT vs REFI Comparison
Compare GALT & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | REFI |
|---|---|---|
| Founded | 2000 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 278.8M |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GALT | REFI |
|---|---|---|
| Price | $4.01 | $10.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 301.3K | 153.0K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.79% |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $48,857,628.00 |
| Revenue This Year | N/A | $17.47 |
| Revenue Next Year | N/A | $0.06 |
| P/E Ratio | ★ N/A | $19.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $9.69 |
| 52 Week High | $7.13 | $13.49 |
Technical Indicators
Market Signals| Indicator | GALT | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 54.74 |
| Support Level | $2.74 | $10.63 |
| Resistance Level | $4.35 | $10.97 |
| Average True Range (ATR) | 0.29 | 0.21 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 35.08 | 34.78 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.